To study efficacy of Rohitak Abhaya Kwath in the management of Non Alcoholic Fatty Liver Disease

A clinical study on the efficacy of Rohitak Abhaya Kwath in the management of Non Alcoholic Fatty Liver Disease - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/083810

Enrollment

Registered

2025-04-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between 18 to 70 years of age irrespective of the sex. 2. Subjects having complaints of indigestion, pain abdomen, anorexia, fatigue, nausea and fulfilling the criteria of diagnosis. 3. Non alcoholic fatty liver- Grade I, Grade II and Grade III

Exclusion criteria

Exclusion criteria: 1. Subjects below 18 years more than 70 years. 2. Pregnancy and lactating mother 3. Any cardiac problem 4. Psychiatric disorders. 5. Stomach ulcer 6. Cancer patients 7. Surgical intervention if any. 8. CLD patients with Ascites

Design outcomes

Primary

Measure	Time frame
To assess the effectiveness of Rohitak Abhaya Kwath in the management of symptomatology of NAFLDTimepoint: 45 Days	—

Secondary

Measure	Time frame
To compare the efficacy of Rohitak Abhaya Kwath with Ursodeoxycholic Acid on LFT, USG WA and Lipid ProfileTimepoint: 15th, 30th and 45th day	—

Countries

India

Contacts

Public ContactDr Shyamanta Kalita

Govt Ayurvedic College & Hospital Guwahati

kalitashyamanta108@gmail.com9707186463

Outcome results